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Abstract 
Aims: Immunological disturbances including innate immunity after a suspected viral infection are considered 
important to the pathogenesis of bile duct lesions in cases of biliary atresia (BA). Herein, we tried to evaluate 
whether natural killer (NK) cells and CX3CL1 (Fractalkine) and its receptor (CX3CR1) are involved in the 
bile duct injury. Methods: Using the section of BA (22 cases) and controls, immunohistochemistry for CD56, 
CD16, CD68, CX3CL1, and CX3CR1 was performed. Moreover, using cultured biliary epithelial cells 
(BECs) and NK cells, the production of CX3CL1 in BECs and the migration of NK cells were evaluated. 
Results: It was found that CD56(-)CD16(+)CD68(-) NK cells were increased around the damaged small and 
large bile ducts in BA and HCV-related chronic hepatitis in comparison with other controls. CX3CL1 was 
strongly expressed on the damaged bile ducts in BA, while this expression was relatively weak or absent in the 
bile ducts of normal liver. The results suggest the CD56(-)CD16(+) NK cells to be involved in the 
development of bile duct injuries in BA. These CD16(+) NK cells were positive for CX3CR1, and attracted 
by CX3CL1 expressed on bile ducts. Further study revealed that stimulation with poly(I:C) (a synthetic 
analogue of viral dsRNA) increased the expression of CX3CL1 on cultured BECs followed by increased 
migrational activity of cultured NK cells. Conclusion: CD56(-)CD16(+) NK cells with reduced NK activity 
may be involved in the bile duct damage in BA, and CD16(+) NK cells expressing CX3CR1 may be attracted 
by and interact with bile ducts expressing CX3CL1.  
 
Key words; biliary tree, biliary epithelial cells, biliary atresia, natural killer cells, innate immunity 
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Introduction 
   Biliary atresia (BA) is a neonatal obstructive cholangiopathy characterized by the progressive destruction 
of extrahepatic bile ducts. Intrahepatic large bile ducts are also involved.1 Clinical and experimental evidence 
suggests that a viral infection triggers the development of bile duct lesions in BA. The infection of newborn 
Balb/c-mice with Reoviridae (rotavirus and reovirus, dsRNA virus) leads to bile duct obstruction and 
cholestasis resembling human BA.1 In this animal model, viral infections of the biliary tree and subsequent 
cellular autoimmunity against the bile ducts are important for progressive cholangiopathy and loss.2,3 
Reoviridae reportedly show epitheliotropism and apoptosis in intestinal epithelial cells.1,2,4-6 We reported that 
human biliary epithelial cells (BECs) possess dsRNA-related innate immune systems via a 
dsRNA-recognizing receptor such as Toll-like receptor 3 (TLR3), suggesting that Reoviridae infections 
directly relate to the pathogenesis of cholangiopathies in BA.7-11  
   Natural killer (NK) cells constitute an important part of the first line of defense against many microbial 
infections, and play a significant role in immunity and the immunopathology of hepatobiliary diseases. The 
majority of NK cells which are strongly cytolytic effector cells fall within the CD56(+) subset. Recently, a 
population of CD56(-)CD16(+) NK cells has been described in human immunodeficiency virus (HIV) and 
hepatitis C virus (HCV)-infected patients: these cells have impaired cytolytic functions and cytokine 
production.12-13 HIV and HCV infections have been strongly associated with a loss of CD56(+) NK cells, at 
least partly compensated for by an expansion in the number of CD56(-)CD16(+) cells.5,12-13 This replacement 
of CD56-expressing NK cells by functionally defective CD56(-)CD16(+) NK cells might be one of the 
mechanisms by which HIV and HCV impair the overall NK cell response. Shivakumar et al reported NK cells 
in the vicinity of intrahepatic bile ducts in infants with BA.14 It remains unclear whether NK cells play an 
important role in the pathology of BA. 
CX3CL1 (Fractalkine) plays an important role in the cell migration to target sites under physiological 
as well as pathological conditions and is expressed on vascular endothelial cells and epithelial cells in 
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response to proinflammatory cytokines and TLR ligands. CX3CR1, a receptor of CX3CL1, is expressed on 
inflammatory cells including NK cells, suggesting that NK cells are attracted by CX3CL1 expressed in the 
liver, particularly around damaged bile ducts. Such a scenario has been shown in bile duct lesions in 
primary biliary cirrhosis (PBC).15  
   In this study, to clarify the participation of NK cells int the pathogenesis of cholangiopathy in BA, 
we first examined immunohistochemically the distribution of NK cells, particularly CD56(-)CD16(+) NK 
cells, in the liver tissue of BA patients. We also examined the expression of CX3CL1 on bile ducts and 
infiltration of mononuclear cells expressing CX3CR1, particularly around damaged bile ducts. Then, the 




Materials and Methods 
I. Tissue studies of liver and bile ducts 
A. Anatomical classification of the biliary tree  
Extrahepatic bile duct consists of the common hepatic and bile ducts, the right and left hepatic ducts, and their 
confluence. The branches of the right and left hepatic ducts are largely divided into the large intrahepatic bile 
duct and small intrahepatic bile ducts. The former roughly correspond to the first to third branches of the right 
and left hepatic ducts. The small bile ducts are further classified into the septal and interlobular bile ducts.16 
The peribiliary glands are present along the extrahepatic bile ducts and the large intrahepatic bile ducts, and 
the peribiliary vascular plexus is also identifiable around the bile ducts. In this study, the hilar bile ducts and 
intrahepatic large bile ducts are collectively called the large bile duct.  
B. Case collection and preparation of liver and bile duct specimens  
1) Case selection: The details of these cases are shown in Table 1. For the examination of small intrahepatic 
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bile ducts, 22 cases of BA, 9 cases of chronic viral hepatitis C (CH-C), 9 cases of nonalcoholic steatohepatitis 
(NASH), and 12 cases of normal liver were examined (43 cases were of needle or wedge liver biopsies and 
the remaining 9 cases, surgically resected). For the large bile duct, 21 cases of BA, 8 autopsy cases of fetus, 
and 4 normal controls were examined (all cases were surgically resected). Normal livers for small intrahepatic 
bile ducts and large bile ducts were from non-neoplastic parts of metastatic liver carcinoma.  
2) Tissue preparation: All of these tissue specimens were fixed in 10% neutral buffered formalin and 
embedded in paraffin. More than 20 consecutive 4-μm-thick sections were cut from each paraffin block, and 
some of them were stained with hematoxylin and eosin (H&E) and Azan-Mallory stain for the identification 
of bile duct lesions. The remaining sections were used for immunohistochemistry. 
 
C. Immunohistochemistry  
Immunostaining was performed using formalin-fixed, paraffin-embedded tissue sections of BA patients and 
controls (other diseases). The primary antibodies and their sources, optimal dilution, and antigen retrieval 
method are shown in Table 2. The small bile ducts and large bile ducts and their surrounding areas were 
mainly examined. 
1) Distribution of CD56(-)CD16(+)CD68(-) NK cells 
Immunostaining: After antigen retrieval (pressure with citric acid method) for 20 minutes, immunostaining 
for CD56 was performed using the CSA II System (biotin-free tyramide signal amplification system, 
DakoCytomation). Color development was performed by a benzidine reaction. After microwaving with citric 
acid, the sections were incubated overnight at 4°C with a primary monoclonal antibody against CD68. The 
sections were then treated with secondary antibodies conjugated to a peroxidase-labeled polymer (EnVision 
system, DakoCytomation). Color development was performed using Histogreen. The sections were 
counterstained with hematoxylin. Expression of CD56 (brown) and CD68 (green) in the cytoplasm of 
mononuclear cells was regarded as positive. Negative controls were carried out. Cells positive for CD56 or 
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CD68 were identified around the small bile ducts and also beneath the large bile duct epithelia. Two areas 
around the small bile ducts and two areas beneath the large bile duct epithelia were photographed (Photograph 
A) in each case. After decolorization by microwaving with citric acid for 5 minutes in which green-colored 
CD68 was abolished, the sections were incubated overnight at 4°C with a primary monoclonal antibody for 
CD16, and the sections were then treated with secondary antibodies conjugated to a peroxidase-labeled 
polymer (EnVision system, DakoCytomation). Color development was performed using Histogreen. The 
sections were counterstained with hematoxylin. Negative controls were carried out. Cells positive for CD56 
(brown) or CD16 (green) were identified around the small bile ducts and also beneath the large bile duct 
epithelia, and two areas in the former and two in the latter in the same areas as photographed in photo A were 
again photographed (Photograph B) in each case. 
Semiquantitative evaluation: Photographs A and B in the same areas were compared, and 
CD56(-)CD16(+)CD68(-) NK cells, which were green in photo B but not photo A, were counted around the 
small bile ducts and also beneath the large bile duct epithelia. The average for the two photographs was 
regarded as the number of CD56(-)CD16(+)CD68(-) NK cells in each case. 
2) Immunostaining of CX3CR1/CD16  
Immunostaining: CX3CR1(+) mononuclear cells were characterized with respect to CD16 NK cells in BA. 
After blocking of the endogenous peroxidase and antigen retrieval for 20 minutes, the sections were incubated 
overnight at 4°C with a polyclonal rabbit anti-CX3CR1 antibody. The sections were then treated with 
secondary antibodies conjugated to a peroxidase-labeled polymer (EnVision system, DakoCytomation). Color 
development was performed by a benzidine reaction. After microwaving with citric acid, the sections were 
incubated overnight at 4°C with a primary monoclonal antibody against CD16. The sections were next treated 
with secondary antibodies conjugated to a peroxidase-labeled polymer (EnVision system, DakoCytomation). 
Color development was performed using Histogreen. The sections were counterstained with hematoxylin. 
Expression of CX3CR1 and CD16 in the cytoplasm of mononuclear cells was regarded as positive. Cells 
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positive for CX3CR1 (brown) or CD16 (green) identified around the small bile ducts and also beneath the 
large bile duct epithelia were evaluated in individual cases. Negative controls were carried out.  
Semiquantitative evaluation: Double positive cells (CX3CR1 is brown and CD16 is green) were counted 
around the small bile ducts (two bile ducts) and beneath the large bile ducts (two areas) in BA patients and 
controls, and the average of two values for each case was regarded as the number of CX3CR1(+)CD16(+) NK 
cells in each case.  
3) Immunostaining of CX3CL1 
Immunostaining: After blocking of the endogenous peroxidase, the sections were incubated in protein block 
solution (DakoCytomation). The sections were incubated overnight at 4°C with primary polyclonal antibodies 
against CX3CL1. The sections were then treated with secondary antibodies conjugated to a peroxidase-labeled 
polymer (EnVision system, DakoCytomation). After a benzidine reaction, the sections were counterstained 
lightly with hematoxylin. Negative controls were also done.  
Semiquantitative evaluation: CX3CL1 expression in bile ducts was evaluated as either absent/faint (±), 
slightly positive (+), or strongly positive (++). 
 
II. Culture studies 
A. Cultures of human BECs 
 A line of human biliary epithelial cells (BECs) was established and cultured as previously 
reported.17 BECs were established from the explant liver of a 24 year-old male with BA. More than 95% of 
the cultured cells were confirmed to be BECs by the expression of biliary-type cytokeratins (CK7 and CK19). 
Informed consent for research was obtained from the patient prior to surgery. This study was approved by the 
Kanazawa University Ethics Committee. Cultured BECs were stimulated with polyinosinic-polycytidylic acid 
[poly(I:C), TLR3 ligand, a synthetic analogue of viral dsRNA; 25 µg/ml; Invitrogen, San Diego, CA, USA] 
and mRNA and supernatant of cells were used in the mRNA analysis and migration assay, respectively.  
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B. RT-PCR for CX3CL1 
For the evaluation of the mRNA of CX3CL1 in cultured BECs, total RNA was isolated and 1µg was 
reverse-transcribed with an oligo-(dT) primer and reverse transcriptase to synthesize cDNA. The cDNA was 
amplified by PCR using specific primers designed to specifically amplify a 262bp portion of CX3CL1. As a 
positive control of the PCR, primers for the GAPDH gene mRNA were used. The PCR products were 
subjected to electrophoresis on 1.5% agarose gels containing ethidium bromide. 
In addition, to carry out relative quantification, real-time quantitative PCR was performed for 
measurements of CX3CL1 mRNA according to a standard protocol using the SYBR Green PCR Master Mix 
and ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Tokyo, Japan). Results are shown as 
relative mRNA expression compared with the level without any treatments (PBS). In addition, real-time 
quantitative PCR was performed for measurements of Notch1, Ascl1, and chromogranin A mRNAs according 
to a standard protocol using the Brilliant II SYBR Green QPCR Reagents and Mx300P QPCR system 
(Stratagene Japan, Tokyo, Japan) and relative gene expression was calculated using the comparative cycle 
threshold method. Specific primers were as follows: CX3CL1 forward, 5'-GATGGCTCCGATATCTCTG-3', 
and Reverse 5'-CTGCTGCATCGCGTCCTTG-3' and glyceraldehyde 3 phosphate dehydrogenase (GAPDH, 
internal positive control), forward, 5’-GGCCTCCAAGGAGTAAGACC-3’, and reverse, 
5’-AGGGGTCTACATGGCAACTG-3’. 
 
C. Migration assay of NK cells with cultured BECs  
1) Preparation of cultured NK cells: NK cells were isolated from the peripheral blood mononuclear cells of a 
healthy volunteer according to MACS protocols of the NK cell isolation kit (MACS, Miltenyi Biotec K.K., 
Tokyo, Japan). These cells were maintained on culture dishes with standard medium, Lymphocyte Growth 
Medium-3 (Takara, Ohtsu, Japan) at 37°C in 95% air and 5% CO2.  
2) Migration assay of NK cells with cultured BECs stimulated by poly(I:C): The chemoattractant activity of 
CX3CL1 secreted by cultured BECs stimulated with poly(I:C) was assessed in 96-well plates assembled with 
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the Cultrex® 96-well collagen I cell invasion assay (Treigen, Gaithersburg, MD) according to the 
manufacturer's directions using isolated NK cells expressing CX3CR1 and showing efficient chemotaxis and 
adherence in a CX3CL1-dependent manner. Briefly, the NK cell suspension was seeded and the supernatant 
of BECs cultured with poly(I:C) for 3 days or the human recombinant CX3CL1 (10ng/mL, PeproTech, Rocky 
Hill, NJ) was added to lower wells at 1:100 or 1:10. After 24 hours, the transferred cells were collected and 
their number was evaluated by optical density (OD).  
 
Statistical analysis  
Numerical data are presented as the mean±standard deviation (SD). Data from different groups were 
compared using a one-way analysis of variance and examined with the Mann-Whitney U-test. Differences in 
the proportions of categorical data were tested using the Chi-square test. The correlation coefficient of two 
factors was evaluated using Spearman’s rank correlation test. For the migration assay of NK cells, Welch's t 
test was used. The results were considered significant if the p value was <0.05.  
 
Results 
I. Tissue studies of liver and bile ducts  
1. Infiltration of CD56(-)CD16(+)CD68(-)NK cells 
Small bile ducts: In normal livers, there were no or few CD56(-)CD16(+)CD68(-) NK cells in portal tracts. In 
contrast, in diseased livers including BA, there were variable numbers of such NK cells admixed with other 
inflammatory cells, and these cells were rather frequent in BA (Fig. 1A,B,C,D). Their numbers counted 
around small bile ducts are plotted in Fig. 1E. The cells were rather dense in BA in comparison with NASH 
and normal livers (p<0.01).  
Large bile ducts: There were no or few CD56(-)CD16(+)CD68(-) NK cells beneath biliary epithelia of the 
large bile duct in normal adult livers, while they were identifiable in BA (Fig. 2A,B,C,D). Their numbers are 
                                                         Okamura  -10- 
plotted in Fig. 2E. They were more abundant in BA than in normal livers (p<0.01). 
 
2. Immunohistochemistry for CX3CL1  
A. Infiltration of CX3CR1(+)CD16(+) mononuclear cells 
Small bile ducts: CX3CR1(+)CD16(+) mononuclear cells admixed with other inflammatory cells were 
frequently present in portal tracts around damaged small bile ducts in cases of BA (Fig. 3A), while such cells 
were sparse in cases of other liver diseases and normal livers (Fig. 3B). Their number in the portal tracts is 
plotted in Fig. 3C. They were rather dense in BA in comparison with other liver diseases and normal livers. 
Large bile ducts: CX3CR1(+)CD16(+) mononuclear cells admixed with other inflammatory cells were found 
around the large bile ducts in cases of BA, but were not found in normal livers. The incidence of these cells is 
shown in Fig. 3D.  
B. Expression of CX3CL1 in bile ducts  
Small bile ducts: In normal livers, small bile ducts were generally negative or faintly positive for CX3CL1, 
and endothelial cells of small vessels of PBP were negative or slightly positive for CX3CL1 (Fig. 4A). In 
CH-C, and NASH livers, small bile ducts were negative or slightly positive for CX3CL1. Small bile ducts of 
BA patients were strongly positive for CX3CL1 (Fig. 4B). The incidence of small bile ducts with mild to 
moderate and strong expression in normal liver, BA and other liver diseases is shown in Fig. 4C. Endothelial 
cells around injured interlobular bile ducts of BA patients also were strongly positive for CX3CL1 and their 
intensity was higher in comparison with other disease controls (Fig. 4A and 4B). 
Large bile ducts: CX3CL1 was not expressed or only faintly expressed in large bile ducts and peribiliary 
glands and PBP in normal livers (Fig. 5A), while it was strongly expressed in biliary epithelial cells of large 
bile ducts and peribiliary glands in cases of BA and also endothelial cells of PBP around large bile ducts in BA 
(Fig. 5B,C), while such expression was faint or absent in normal livers. The incidence of bile ducts with mild 
to moderate and strong expression of CX3CL1 is shown in Fig. 5D. 
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II. Culture studies 
1. Expression of CX3CL1 mRNA in cultured BECs treated with poly(I:C) 
RT-PCR revealed that the amplicon of CX3CL1 mRNA could not be detected in cultured BECs without any 
stimulants (PBS), whereas treatment with poly(I:C) induced its expression (Fig. 6A). As shown in Fig. 6B, 
real-time PCR analysis revealed that treatment with poly(I:C) significantly up-regulated the expression of 
CX3CL1 mRNA 21.9-fold (Fig. 6B). 
 
2. Migration of NK cells  
Optical density reflecting the number of NK cells that transmigrated was significantly increased in the bottom 
chamber containing recombinant CX3CL1 and supernatant of poly(I:C)-treated BECs, compared with that 
containing the negative control medium (PBS). The effect of the supernatant was concentration 
(dose)-dependent (Fig. 7).   
 
Discussion 
   The findings obtained in this study can be summarized as follows: i) CD56(-)CD16(+) NK cells were 
increased around the small bile ducts and beneath the biliary epithelia of large bile ducts in comparison with  
other diseases and normal livers, ii) such CD16(+) cells expressed CX3CR1, a receptor of CX3CL1, iii) 
CX3CL1 was strongly expressed in BECs of small bile ducts and also of large bile ducts in BA, and iv) 
stimulation with poly(I:C) (a synthetic analogue of viral dsRNA) increased the expression of CX3CL1 on 
cultured BECs and increased migration of cultured NK cells.  
The pathogenesis of BA may be the virus-induced autoimmune-mediated injury of bile ducts.6 In fact, 
Reoviridae (type 3 reovirus and type C rotavirus) and herpes virus including cytomegalovirus have all been 
considered possible candidates for the initiating agent.1 Studies in the rotavirus mouse model of BA indicate 
that a viral infection of the biliary epithelium is an initial event leading to biliary inflammation and obstruction 
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and autoreactive T cells and autoantibodies specific to bile duct epithelia have been reported.3,18 Specific host 
factors related to innate and acquired immunopathologic processes with respect to viral infection may also 
play a key role in experimental BA.18 Recently, many genetic studies, moreover, have recently reported. 
Genomic study including genome-wide association study identified a susceptibility locus for BA on 10q24.2 
and 2q37.3.19-20 Moreover, DNA hypermethylation at the CD11a locus in CD4+ cells, polymorphisms of 
vascular endothelial growth factor gene, and two microRNAs (miR-29a/29b1) may contribute significantly to 
BA susceptibility, but polymorphisms of IL-4, IL-18, IFN-γ genes were unlikely.21-26 These genetic analyses 
revealed a link to the susceptibility to BA with respect of immunopathologic processes. 
Recent studies showed the roles of NK cells in addition to T cells in the destruction of extrahepatic bile 
ducts in BA.18,27 That is, the inflammatory milieu from portal tracts and/or biliary remnants showed greater 
numbers of T cells and NK cells, and up-regulation of CD8(+) costimulatory molecules in BA.27 In 
experimental BA, activated NK cells were reportedly the most abundant cells in extrahepatic bile ducts and 
such NK cells were regarded as key initiators of bile duct injury.14 However, the exact roles of NK cells and 
their phenotypic and functional alterations have not been studied in BA. 
   The CD56(-)CD16(+) NK subset is greatly expanded in HIV-viremic individuals.28 The CD56(-) NK 
fraction was associated with extremely poor in vitro cytotoxic functions.28 In addition, the secretion of certain 
cytokines important for initiating antiviral immune responses was markedly reduced in the CD56(-) NK cells. 
Elevated levels of CD56(-) NK cells are also found in many CH-C patients.5,6 These CD56(-) NK cells were 
functionally impaired with respect to cytokine production upon target cell recognition.29 Furthermore, high 
levels of these cells reveal a disturbance in innate cellular immunity that is associated with an impaired ability 
to respond to antiviral treatment with IFN-α and ribavirin. Taken together, these findings suggest that the 
expansion of this highly dysfunctional CD56(-) NK cell subset in humans infected with HIV-1 and HCV 
largely accounts for the impaired function of the total NK cell population.12 So far, such issues have not been 
examined in BA.  
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   It was found in this study that CD56(-)CD16(+) NK cells were increased around the damaged small and 
large bile ducts in BA, and the proportion of these cells was relatively high in BA in comparison with controls,  
suggesting that increased CD56(-)CD16(+) NK cells with reduced NK activities were involved in the 
development of bile duct injuries in BA. It seems possible that inadequate removal of BECs infected with 
cholangiotrophic virus by abundant CD56(-)CD16(+) NK cells with reduced antiviral activities leads to the 
induction of secondary immunization against the cholangiotrophic virus as well as BECs in BA. 
Cross-reactivity between viral and self-antigens is also proposed to trigger secondary autoimmunity.2,6 This 
may be in turn followed by extensive autoimmune-mediated destruction of the bile ducts by CD8(+) cytotoxic 
T cells and other effector cells. CD8(+) T cells were reportedly necessary for induction of bile duct injury and 
obstruction in an experimental model of BA with autoimmune features.30  
   It was also found in this study that CD16(+) NK cells were positive for CX3CR1, and CX3CL1 was 
strongly expressed on the damaged bile ducts in BA. While the expression of CX3CL1 was relatively weak or 
absent in the bile ducts of normal liver and CH-C, CX3CL1 was also strongly expressed in the damaged bile 
ducts in PBC, in which the interaction of CX3CR1-expressing lymphocytes and CX3CL1-expressing bile 
ducts and endothelial cells of PBP is important in the bile duct destruction.15 CX3CL1 is a chemokine with 
both chemoattractant and cell-adhesive functions, and in the intestine it is involved with its receptor CX3CR1 
in the chemoattraction and recruitment of intraepithelial lymphocytes.15  It seems likely that CD16(+) NK 
cells with expression of CX3CR1 may be chemoattracted and infiltrate around the bile ducts expressing 
CX3CL1 and this may be followed by the immunological interaction of NK cells and bile ducts, possibly 
virus infected. 
 Expression of CX3CL1 in human BECs in response to a TLR3 ligand, poly(I:C), was examined using a 
human intrahepatic BEC line. Consequently, the expression of CX3CL1 mRNA was low under normal 
conditions, but significantly up-regulated by the stimulation with poly(I:C). We have already reported that 
BECs express multiple functionally active TLRs and respond to the corresponding bacterial or viral TLR 
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ligands including poly(I:C).7 Moreover, we previously demonstrated the diffuse expression of TLR3 in 
extrahepatic and intrahepatic bile ducts of patients with biliary atresia. Therefore, BECs infected by 
Reoviridae (reovirus and rotavirus) having a double-strand RNA are speculated to induce the expression of 
CX3CL1 via biliary innate immunity in biliary atresia patients. Moreover, the chemotaxis of human NK cells 
expressing the CX3CL1 ligand CX3CR1, and showing efficient chemotaxis and adherence in a 
CX3CL1-dependent manner was assayed using a cell invasion assay kit. The human NK cells showed 
chemotaxis toward recombinant CX3CL1 and also the culture medium which was speculated to contain 
CX3CL1 secreted by poly(I:C)-stimulated BECs. Therefore, dsRNA viruses in the microenvironment of 
injured bile ducts resulting from BA induce the upregulation of CX3CL1 expression in BECs, followed by the 
chemoattraction of CX3CR1-expressing mononuclear cells including NK cells, and their adhesion to BECs. 
    The elevation of CD56(-)CD16(+) NK subset was reported in the peripheral blood mononuclear cell 
of HCV- and HIV- infected patients.13 We could confirm the increase of CD56(-)CD16(+)CD68(-) NK cells 
in liver specimens of CH-C as well as BA by the immunohistochemistry, though statistical significance was 
not obtained in CH-C, compared with NASH and normal liver. Therefore, impaired NK function caused by an 
increased CD56(-)CD16(+) NK subset in liver tissue is presumable in BA and CH-C, but not NASH or 
normal livers. Moreover, it is speculated that these NK cells were attracted by CXCL1 produced in BECs via 
an innate immunity against virus. This scenario might be common in several virus-related diseases including 
CH-C and BA.   
 
Take home messages 
-  CD56(-)CD16(+) NK cells with reduced NK activities accumulated around damaged small and large bile 
ducts may be involved in the development of BA.  
-  By the biliary innate immunity for dsRNA, BECs expressed CX3CL1, which may attract CD16(+) NK 
cells around the damaged bile ducts.  
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-  These findings may be followed by acquired immunity against the infected bile ducts.  
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Table 1. Main clinical features of cases examined 
 
---------------------------------------------------------------------------------------------------------------------
Cases for the study of intrahepatic small bile ducts 
                             Age (mean±SD; range)     Sex (M:F)  
 Biliary atresia (n=22)             1.77±0.86 m; 0.7－12 m  10:12   
 Chronic viral hepatitis C (n=9) a)      59.0±13.0 y; 27－72 y        4:5 
 Nonalcoholic steatohepatitis (n=9) b)  44.4±14.4 y; 25－69 y        3:6   
 Adult normal liver (n=12)     62.1±13.1 y; 47－82 y        6:6  
 
Cases for study of large bile ducts                                                                               
          Age (mean±SD; range) Sex (M:F)  
  Biliary atresia (n=21)        1.71±0.81 m; 0.7－12 m    9:12 
 Normal common bile duct (fetus) c) (n=8)                    6:2 
 Adult normal liver d) (n=4)          58.7±17.0 y; 42－76 y   2:2  
---------------------------------------------------------------------------------------------------------------------                                                                                    
m, months; y, years; M, male; F, female; n, number of cases; a), staging; stage 1, 6 cases; stage 
2, 0 cases; stage 3, 0 cases; stage 4, 3 cases ; b), staging; stage 1, 2 cases; stage 2, 3 cases; stage 
3, 3 cases; stage 4, 1 cases ; c), autopsy cases of fetus ; d), surgical cases  
                                                         Okamura  -20- 
 
 




Type of antibody  
and immunized 
animal 


































 1： 500 
 
 
 1： 1000  
Leica, Tokyo, Japan  
 
Nichirei, Tokyo, Japan  
 
Nichirei, Tokyo, Japan  
 
Immuno-Biological 
Laboratories, Fujioka, Japan  
Immuno-Biological 












*, already diluted; microwave, microwaved in 10mM citrate buffer for 20 minutes in a 
microwave oven; pressure cooker, treated in 10mM citrate buffer pressure cooker  
 
 
                                                         Okamura  -21- 
Figure legends 
 
Fig. 1    Density of CD56(-)CD16(+)CD68(-) NK cells around intrahepatic small bile ducts. (A,C) 
Expression of CD56 (brown) and CD68 (green). (B,D) Expression of CD56 (brown) and CD16 
(green). Two photographs in the same areas of NASH (A,B) were compared. 
CD56(-)CD16(+)CD68(-) NK cells were green in photo B but not photo A. There were no or few 
CD56(-)CD16(+)CD68(-) NK cells in portal tracts. In contrast, in BA (C,D), there were variable 
numbers of such NK cells admixed with other infiltrated inflammatory cells. (E) The number of such 
NK cells around small bile ducts is rather high in BA in comparison with NASH and normal 
livers. Mean±SD in BA, CVH-C, NASH, and adult normal livers were 4.37±3.83, 3.00±2.06, 
0.11±0.33, and 0.58±0.66, respectively. Effect size and confidence interval; BA vs CVH-C (effect 
size=0.18, confidence interval -1.39 to 4.14), BA vs NASH (effect size=051, confidence interval 1.63 
to 6.90), and BA vs adult normal livers (effect size=0.50, confidence interval 1.51 to 6.07). Bars 
indicate the mean±SD. *<0.01. 
 
Fig. 2    Density of CD56(-)CD16(+)CD68(-) NK cells around large bile ducts. (A,B) There were no or few 
CD56(-)CD16(+)CD68(-) NK cells beneath biliary epithelia of the large bile duct in normal adult 
livers. (C,D) Such NK cells were identifiable in BA. (E) These cells were more abundant in BA than in 
normal livers. Mean±SD in BA, CBD of fetus, and adult large bile ducts were 2.50±2.34, 2.00±1.41, 
and 0.33±0.57, respectively. Effect size and confidence interval; BA vs CBD of fetus (effect size=0.08, 
confidence interval -1.44 to 2.20) and BA vs adult large bile ducts (effect size=0.58, confidence 
interval 0.66 to 3.10). Bars indicate the mean±SD. *<0.01. 
 
Fig. 3    CX3CR1(+)CD16(+) mononuclear cells around intrahepatic bile ducts. (A) CX3CR1(+)CD16(+) 
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mononuclear cells were frequently present in portal tracts around damaged small bile ducts in BA. (B) 
Such cells were sparse in normal livers and other liver diseases. (C) They were rather dense in BA in 
comparison with other liver diseases and normal livers. Mean±SD in BA, CVH-C, NASH, and adult 
normal livers were 4.30±3.03, 1.88±1.05, 0.77±0.83, and 1.50±1.37, respectively. Effect size and 
confidence interval; BA vs CVH-C (effect size=0.39, confidence interval 0.28 to 4.55), BA vs NASH 
(effect size=053, confidence interval 1.41 to 5.64), and BA vs adult normal livers (effect size=0.39, 
confidence interval 0.166 to 5.44). (D) CX3CR1(+)CD16(+) mononuclear cells were found around 
the large bile ducts in BA, but not in normal livers of fetuses or adults. Mean±SD in BA, CBD of fetus, 
and adult large bile ducts were 6.66±2.41, 0.50±0.53, and 0.75±0.50, respectively. Effect size and 
confidence interval; BA vs CBD of fetus (effect size=0.81, confidence interval 4.38 to 7.95) and BA vs 
adult large bile ducts (effect size=0.71, confidence interval 3.37 to 8.47). Bars indicate the mean±SD. 
*<0.05. 
 
Fig. 4    Expression of CX3CL1 in intrahepatic small bile duct epithelia. (A) Normal livers. Small bile ducts 
were generally negative or faintly positive for CX3CL1. (B) BA. Small bile ducts were strongly 
positive for CX3CL1. (C) The incidence of small bile ducts with mild to moderate and strong 
expression in normal liver, BA and other liver diseases.  
 
Fig. 5    Expression of CX3CL1 in large bile duct epithelia. (A) CX3CL1 was not or faintly expressed in 
large bile ducts and peribiliary glands and PBP of normal livers. (B,C) It was strongly expressed in 
biliary epithelial cells of large bile ducts and peribiliary glands and also endothelial cells of PBP around 
large bile ducts in BA. (D) The incidence of bile ducts with mild to moderate and strong expression of 
CX3CL1. *<0.01. 
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Fig. 6    Expression of CX3CL1 mRNA in cultured human biliary epithelial cells (BECs).  (A) 
Representative images of RT-PCR using cultured BECs. The amplicon of CX3CL1 mRNA could not 
be detected without the stimulant (-). de novo expression was found in the poly(I:C)-treated cells 3h 
after treatment with poly(I:C). (B) Quantitative analysis using real-time PCR revealed the increase in 
the level of CX3CL1 mRNA on poly(I:C) treatment to be 21.9±2.2 (mean±SEM)-fold and statistically 
significant compared to that without treatment (effect size=0.97, confidence interval -26.09 to 
-15.61). Results were obtained from four independent experiments. Bars indicate the mean±SEM. 
*<0.05. 
 
Fig. 7    Migration assay of NK cells.  Optical density (OD) reflecting the number of transmigrated NK 
cells was significantly increased in the lower chamber containing recombinant CX3CL1 
(10ng/ml, OD=0.49±0.02 (mean±SEM), effect size=0.66, confidence interval -0.09 to -0.01) and 
supernatant of poly(I:C)-treated BEC diluted 1:100 (OD=0.47±0.02, effect size=0.51, confidence 
interval -0.08 to 0.01) and 1:10 (OD=0.51±0.02, effect size=0.73, confidence interval -0.12 to -0.02), 
compared with that containing the negative control medium (PBS, OD=0.44±0.008). Results were 
obtained from eight independent experiments. Bars indicate the mean±SEM. *<0.05. 
Table 1. Main clinical features of cases examined 
Cases for the study of intrahepatic small bile ducts 
 
                                                                          Age (mean±SD; range)       Sex (M:F)  
 Biliary atresia (n=22)          1.77±0.86 m; 0.7－12 m  10:12   
 
 Chronic viral hepatitis C (n=9) a)    59.0±13.0 y; 27－72 y    4:5 
 
 Nonalcoholic steatohepatitis (n=9) b)   44.4±14.4 y; 25－69 y     3:6   
 
 Adult normal liver (n=12)     62.1±13.1 y; 47－82 y     6:6  
 
 
Cases for study of large bile ducts 
 
                                                                           Age (mean±SD; range)    Sex (M:F)  
   Biliary atresia (n=21)       1.71±0.81 m; 0.7－12 m    9:12 
 
 Normal common bile duct (fetus) c) (n=8)         6:2 
 
 Adult normal liver d) (n=4)        58.7±17.0 y; 42－76 y    2:2 
 
m, months; y, years; M, male; F, female; n, number of cases; a), staging; stage 1, 6 cases; stage 2, 0 
cases; stage 3, 0 cases; stage 4, 3 cases ; b), staging; stage 1, 2 cases; stage 2, 3 cases; stage 3, 3 cases; 
stage 4, 1 cases ; c), autopsy cases of fetus ; d), surgical cases 
Table 2. Antibodies used in this study 
Primary antibody 
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Type of antibody  and 
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Fig. 1E Density of CD56(-)CD16(+)CD68(-) NK cells around intrahepatic small bile ducts 
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Fig.3C CX3CR1(+)CD16(+) monomuclear cells around intrahepatic bile ducts 
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Fig. 3D CX3CR1(+)CD16(+) mononuclear cells around large bile ducts 
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Fig. 4C Expression of CX3CL1 in intrahepatic small bile duct epithelia 
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±, absent/faint; +, slightly positive; ++, strongly positive 
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